Related Experiment Videos
How the host 'sees' pathogens: global gene expression responses to infection
1Departments of Medicine, and Microbiology and Immunology, Stanford University, Stanford, CA 94305-5124, USA.
Current Opinion in Immunology
|March 14, 2000
Summary
New DNA microarray technology reveals how host cells perceive and differentiate between various microbial pathogens at the gene expression level, offering insights into infection dynamics.
Area of Science:
- Immunology
- Microbiology
- Genomics
Background:
- Innate immune responses are generally considered stereotyped, while adaptive responses are more varied but limited in mechanisms.
- A significant disparity exists between the diversity of microbial pathogens and the host's restricted response repertoire.
- The limitations of traditional analytic tools may obscure a more complex host-pathogen interaction.
Purpose of the Study:
- To investigate host gene expression responses to microbial pathogens using DNA microarray technology.
- To determine how host cells perceive and discriminate between different microbial agents.
- To explore the host-pathogen relationship in greater detail than previously possible.
Main Methods:
- Utilized DNA microarray technology to analyze global gene expression in host cells.
- Examined host cellular responses to various microbial pathogens.
- Assessed the discriminatory capacity of host responses at the gene expression level.
Main Results:
- DNA microarrays enable detailed examination of host gene expression in response to pathogens.
- The technology allows for the study of how host cells 'see' pathogens.
- It provides insights into the host's ability to differentiate between various microbial agents.
Conclusions:
- DNA microarray technology offers a powerful tool to dissect host-pathogen interactions at a global gene expression level.
- This approach can reveal the complexity of host responses previously underestimated.
- Potential applications include identifying microbial determinants, understanding temporal dynamics, and developing novel therapeutic strategies.